← Evidence map

TrialClinical pharmacology in drug development2021

A Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants.

Katie Zomorodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32935460